Literature DB >> 2590460

Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiol.

T Loftsson, N Bodor.   

Abstract

The effect of 2-hydroxypropyl-beta-cyclodextrin (2-HPCD) on the aqueous solubility of 18 drugs possessing different physiochemical properties was investigated. The largest increase in aqueous solubility was obtained with very lipophilic drugs with low aqueous solubility and the enhancement was larger at low temperature than at high temperature. In many cases a linear relationship exists between the drug solubility and the 2-HPCD concentration. Ionization of a drug molecule enhanced the solubility effects of 2-HPCD, resulting in greater aqueous solubility than if either method was used by itself. 2-HPCD was found to be an effective transdermal permeability enhancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590460

Source DB:  PubMed          Journal:  Acta Pharm Nord        ISSN: 1100-1801


  3 in total

1.  3-O-Methylquercetin from Achyrocline satureioides-cytotoxic activity against A375-derived human melanoma cell lines and its incorporation into cyclodextrins-hydrogels for topical administration.

Authors:  Eduarda Doneda; Sara Elis Bianchi; Vanessa Pittol; Tainá Kreutz; Juliete Nathali Scholl; Irene L Ibañez; Candelaria Bracalente; Hebe Durán; Fabrício Figueiró; Fábio Klamt; Valquiria Linck Bassani
Journal:  Drug Deliv Transl Res       Date:  2021-01-06       Impact factor: 4.617

2.  Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts.

Authors:  Udaya K Kotreka; Vicki L Davis; Moji C Adeyeye
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

3.  Comparison of Aqueous and 1-Octanol Solubility as well as Liquid-Liquid Distribution of Acyclovir Derivatives and Their Complexes with Hydroxypropyl-β-Cyclodextrin.

Authors:  Małgorzata Koźbiał; Paweł Gierycz
Journal:  J Solution Chem       Date:  2013-04-26       Impact factor: 1.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.